Organoids are three-dimensional miniature models of organs, grown in a dish. They have become a valuable tool for studying ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

A hidden communication network between brain cells and glioblastoma tumors may be key to slowing this aggressive cancer.

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

UNIGE scientists developed an algorithm able to anticipate the risk of cancer metastasis and recurrence. Group of human colon ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

Cancer Research Institute, New York, NY, USA. The cancer cell therapy landscape continues to evolve rapidly. In 2024, the first approvals of tumour-infiltrating lymphocyte (TIL) and T cell receptor ...

ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA damage response. 3,4 Upon PARG inhibition, the agent is intended to ...